Clinical Trial Update: Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

View source ↗

Summary

This document describes an ongoing longitudinal cohort study evaluating immune-related adverse events in solid tumor patients treated with immune checkpoint inh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Shantou University Medical College | Conditions: Solid Tumor, Immune-Related Adverse Events | Status: RECRUITING